Terms: = Breast cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Treatment
35239 results:
1. Patient experiences and needs in cancer care- results from a nationwide cross-sectional study in Germany.
Ziegler E; Klein J; Kofahl C
BMC Health Serv Res; 2024 May; 24(1):572. PubMed ID: 38698426
[TBL] [Abstract] [Full Text] [Related]
2. Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial.
Fehm T; Cottone F; Dunton K; André F; Krop I; Park YH; De Laurentiis M; Miyoshi Y; Armstrong A; Borrego MR; Yerushalmi R; Duhoux FP; Takano T; Lu W; Egorov A; Kim SB
Lancet Oncol; 2024 May; 25(5):614-625. PubMed ID: 38697155
[TBL] [Abstract] [Full Text] [Related]
3. Targeted photodynamic therapy technique of Janus nanoparticles on breast cancer.
Montaseri H; Abrahamse H
Artif Cells Nanomed Biotechnol; 2024 Dec; 52(1):270-277. PubMed ID: 38696132
[TBL] [Abstract] [Full Text] [Related]
4. Serial Postoperative Circulating Tumor DNA Assessment Has Strong Prognostic Value During Long-Term Follow-Up in Patients With breast cancer.
Shaw JA; Page K; Wren E; de Bruin EC; Kalashnikova E; Hastings R; McEwen R; Zhang E; Wadsley M; Acheampong E; Renner D; Gleason KLT; Ambasager B; Stetson D; Fernandez-Garcia D; Guttery D; Allsopp RC; Rodriguez A; Zimmermann B; Sethi H; Aleshin A; Liu MC; Richards C; Stebbing J; Ali S; Rehman F; Cleator S; Kenny L; Ahmed S; Armstrong AC; Coombes RC
JCO Precis Oncol; 2024 Apr; 8():e2300456. PubMed ID: 38691816
[TBL] [Abstract] [Full Text] [Related]
5. Evaluating Recurrence Risk in Patients Undergoing breast-conserving Surgery Using E-cadherin Staining as a Biomarker.
Kao CN; Chen CC; Chu WL; Luo CW; Huang WL; Moi SH; Hou MF; Pan MR
In Vivo; 2024; 38(3):1143-1151. PubMed ID: 38688621
[TBL] [Abstract] [Full Text] [Related]
6. A Comparative Analysis of Implant-sparing Plan
Onal C; Bozca R; Dolek Y; Elmali A; Guler OC
In Vivo; 2024; 38(3):1412-1420. PubMed ID: 38688603
[TBL] [Abstract] [Full Text] [Related]
7. [Malignant Adenomyoepithelioma of the breast:Report of One Case and Literature Review].
Zhao Y; Wen WJ; Zhang XD; An FX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Apr; 46(2):301-306. PubMed ID: 38686730
[TBL] [Abstract] [Full Text] [Related]
8. breast density knowledge and willingness to delay treatment for pre-operative breast cancer imaging among women with a personal history of breast cancer.
Smith RE; Sprague BL; Henderson LM; Kerlikowske K; Miglioretti DL; Wernli KJ; Onega T; diFlorio-Alexander RM; Tosteson ANA
Breast Cancer Res; 2024 Apr; 26(1):73. PubMed ID: 38685119
[TBL] [Abstract] [Full Text] [Related]
9. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
[TBL] [Abstract] [Full Text] [Related]
10. Activation of the MEK/ERK Pathway Mediates the Inhibitory Effects of Silvestrol on Nasopharyngeal Carcinoma Cells via RAP1A, HK2, and GADD45A.
Yu LR; Han XZ; Tang YZ; Liu D; Luo XQ; Qiu XW; Feng J; Yuan WX; Ding JY
Front Biosci (Landmark Ed); 2024 Apr; 29(4):160. PubMed ID: 38682208
[TBL] [Abstract] [Full Text] [Related]
11. Design and Evaluation of NSAID Derivatives as AKR1C3 Inhibitors for breast cancer treatment through Computer-Aided Drug Design and In Vitro Analysis.
Fonseca-Benítez V; Acosta-Guzmán P; Sánchez JE; Alarcón Z; Jiménez RA; Guevara-Pulido J
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675620
[TBL] [Abstract] [Full Text] [Related]
12. Identification of a Gene Expression Signature to Predict the Risk of Early Recurrence and the Degree of Immune Cell Infiltration in Triple-negative breast cancer.
Sato K; Miura K; Tamori S; Akimoto K
Cancer Genomics Proteomics; 2024; 21(3):316-326. PubMed ID: 38670590
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of large language models in breast cancer clinical scenarios: a comparative analysis based on ChatGPT-3.5, ChatGPT-4.0, and Claude2.
Deng L; Wang T; Yangzhang ; Zhai Z; Tao W; Li J; Zhao Y; Luo S; Xu J
Int J Surg; 2024 Apr; 110(4):1941-1950. PubMed ID: 38668655
[TBL] [Abstract] [Full Text] [Related]
14. Real-World treatment Patterns and Clinical Outcomes among Patients Receiving CDK4/6 Inhibitors for Metastatic breast cancer in a Canadian Setting Using AI-Extracted Data.
Moulson R; Feugère G; Moreira-Lucas TS; Dequen F; Weiss J; Smith J; Brezden-Masley C
Curr Oncol; 2024 Apr; 31(4):2172-2184. PubMed ID: 38668064
[TBL] [Abstract] [Full Text] [Related]
15. True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations-Brief Report.
Hoffmann M; Banz Y; Halter J; Schoumans J; Tchinda J; Bacher U; Pabst T
Curr Oncol; 2024 Apr; 31(4):2067-2075. PubMed ID: 38668056
[TBL] [Abstract] [Full Text] [Related]
16. The Efficacy of Fat Grafting on Treating Post-Mastectomy Pain with and without breast Reconstruction: A Systematic Review and Meta-Analysis.
Chen J; Alghamdi AA; Wong CY; Alnaim MF; Kuper G; Zhang J
Curr Oncol; 2024 Apr; 31(4):2057-2066. PubMed ID: 38668055
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic Factors Associated with Tumor Recurrence and Overall Survival in Soft Tissue Sarcomas of the Extremities in a Colombian Reference cancer Center.
Díaz Casas SE; Villacrés JM; Lehmann Mosquera C; García Mora M; Mariño Lozano I; Ángel Aristizábal J; Suarez Rodríguez R; Duarte Torres CA; Sánchez Pedraza R
Curr Oncol; 2024 Mar; 31(4):1725-1738. PubMed ID: 38668034
[No Abstract] [Full Text] [Related]
18. Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study.
Park MH; Seo JH; Park JH; Seong MK; Park KU; Kim MK; Chang M; Koh SJ; Lee MH; Lim ST; Yoo YB; Oh SY; Kim SH; Ahn KY; Park TH; Ju H; Baek EH; Kim S; Kim N; Lee E; Kim TH
Expert Opin Biol Ther; 2024 Apr; 24(4):305-312. PubMed ID: 38664937
[TBL] [Abstract] [Full Text] [Related]
19. Weight management personas of breast cancer patients undergoing chemotherapy in China: a multi-method study.
Li X; Zhang N; Yang J; Geng Z; Zhou J; Zhang J
BMC Med Inform Decis Mak; 2024 Apr; 24(1):108. PubMed ID: 38664653
[TBL] [Abstract] [Full Text] [Related]
20. The efficiency and safety of low-dose apatinib combined with oral vinorelbine in pretreated HER2-negative metastatic breast cancer.
Huang JY; Chen XL; Xie XF; Song L; Chen LP; Lan XF; Bai X; Chen X; Du CW
Cancer Med; 2024 Apr; 13(8):e7181. PubMed ID: 38659376
[TBL] [Abstract] [Full Text] [Related]
[Next]
